Corrigendum to “Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors” [Eur. J. Pharmacol. 477 (2003) 227–234]
about
Corrigendum to “Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors” [Eur. J. Pharmacol. 477 (2003) 227–234]
description
im Februar 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2004
@uk
name
Corrigendum to “Further eviden ...... Pharmacol. 477 (2003) 227–234]
@en
Corrigendum to “Further eviden ...... ptors” [Eur. J. Pharmacol. 477
@nl
type
label
Corrigendum to “Further eviden ...... Pharmacol. 477 (2003) 227–234]
@en
Corrigendum to “Further eviden ...... ptors” [Eur. J. Pharmacol. 477
@nl
prefLabel
Corrigendum to “Further eviden ...... Pharmacol. 477 (2003) 227–234]
@en
Corrigendum to “Further eviden ...... ptors” [Eur. J. Pharmacol. 477
@nl
P2093
P50
P1476
Corrigendum to “Further eviden ...... Pharmacol. 477 (2003) 227–234]
@en
P2093
Alfio Bertolini
Carla Bazzani
Chiara Mioni
Maria Michela Cainazzo
Paolo Grieco
Sheila Leone
P356
10.1016/J.EJPHAR.2003.11.053
P407
P577
2004-02-01T00:00:00Z